RxAnte Appoints James Kalustian as New Chief Operating Officer

Share Article

Industry veteran to guide company’s continuing expansion and growth.

News Image
Jim’s experience in health care informatics and analytics, as well as in helping to scale rapidly growing organizations, will be invaluable in guiding the development of our company.

RxAnte, Inc., a health care analytics company providing a new and innovative approach for improving medication management, announced the appointment of James “Jim” Kalustian as Chief Operating Officer. Kalustian brings more than 20 years of expertise in health care and life sciences to RxAnte’s current team of health care and IT industry leaders.

As Chief Operating Officer, Kalustian will focus on scaling operations, building RxAnte’s infrastructure and honing the organization’s go-to-market systems. In addition to this role, Kalustian will maintain his position as Chairman of the Board of Ambassadors Group, Inc. (NASDAQ: EPAX).

“RxAnte has defined a brand new approach to managing medication use based on a combination of analytics, decision support and subject matter expertise,” said Josh Benner, President and CEO of RxAnte. “Our concept is gaining traction with a wide range of organizations from health plans to pharmaceutical companies and we are growing rapidly. In this pivotal COO role, Jim’s experience in health care informatics and analytics, as well as in helping to scale rapidly growing organizations, will be invaluable in guiding the development of our company.”

Before joining RxAnte, Kalustian was the senior vice president of Network Development and co-founder of Health Resources Information Network (HRInet), a company which facilitated and organized resource networks of specialist physicians.

Prior to this, Kalustian managed operations and profit and loss for the payor, biopharmarmaceutical, provider, retail and consumer products units in his role as Vice President and General Manager of the Emerging Markets business unit at Fair Isaac Corporation. He also served as acting vice president of FICO’s Innovation Management unit where he spearheaded the development and commercialization of many of FICO’s health care and retail analytics products.

“I have spent the better part of two decades working with health care related organizations,” said Kalustian. “I understand both the opportunities and challenges of working within this continuously evolving industry and admire how RxAnte has translated its vision for health care improvement into a reality. I am happy to be a part of this organization and help it realize its potential.”

Kalustian has also served as Chief Operating Officer and member of the Board of Directors of Braun Consulting, Inc. (NASDAQ: BRNC), and was a co-founder of Vertex Partners, a customer-focused strategic consulting firm that joined Braun in 1999. He holds an A.B. from Harvard University and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.


About RxAnte
RxAnte is a health care improvement company that targets, manages and evaluates medication management programs to improve outcomes and lower costs. The company’s patent-pending predictive analytics and decision support solutions turn ordinary claims data into actionable insights and smart recommendations that help health care organizations and the populations they serve use medications more effectively, improve outcomes and save costs. For more information, please visit http://www.RxAnte.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Leigh Canavan
Email >

Kimberly McEnaney
Email >
Visit website